Women's Brain Health: A Trillion-Dollar Economic Opportunity

Ignoring women's health, especially brain health, represents a substantial economic oversight. Closing this gap could inject $1 trillion in annual incremental GDP into the global economy. Women often spend a greater proportion of their lives in poor health, leading to reduced workforce productivity and increased strain on healthcare systems.

Conditions like Alzheimer's disproportionately affect women, who comprise nearly two-thirds of those diagnosed and more than 60% of caregivers. The economic toll of dementia in the U.S. alone is estimated at $781 billion annually, including unpaid caregiving labor. Addressing menopause symptoms, a neurological event impacting cognition, also presents significant economic benefits, yet employer-provided benefits are scarce.

The chronic underfunding of women's brain health stems from a historical research default to men's health, creating an evidence gap that deters investment. Only 6% of private healthcare investment targets women's health, primarily in reproductive areas. However, focusing on underserved therapeutic areas for women could unlock over $100 billion by 2030, highlighting a critical and correctable economic opportunity.